Skip to main content

and
  1. No Access

    Article

    A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills?

    Amongst the unanswered questions regarding prostate cancer (PCa), the optimal management of oligometastatic disease remains one of the major concerns of the scientific community. The very existence of this cat...

    Amine Slaoui, S. Albisinni, F. Aoun, G. Assenmacher in World Journal of Urology (2019)

  2. No Access

    Article

    Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients

    Corticosteroid agents (CA) are widely used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) either as concomitant treatment with active agents such as docetaxel, cabazitaxel and abir...

    S. Sideris, F. Aoun, C. N. Martinez in Journal of Endocrinological Investigation (2016)

  3. No Access

    Article

    A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer

    Focal therapy is an emerging mini-invasive treatment modality for localized prostate cancer aimed to reduce the morbidity associated with radical therapy while maintaining optimal cancer control. We report the...

    R van Velthoven, F Aoun, Q Marcelis, S Albisinni in Prostate Cancer and Prostatic Diseases (2016)